United Kingdom· GB-APID-4845411000001100
Fasturtec 1.5mg powder and solvent for solution for infusion vials
A rasburicase product containing rasburicase, registered in United Kingdom by Sanofi. The same ATC class is registered in 13 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Rasburicase is registered in 13 of 19 countries.
Countries holding a registration under ATC V03AF07 (rasburicase), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Rasburicase · ATC V03AF07
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Rasburicase
- Manufacturer
- Sanofi
- Country
- United Kingdom (GB)
- ATC code
- V03AF07
- ATC class
- Rasburicase
- Defined daily dose
- 14 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5000283109532
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
25 interactions on record for rasburicase.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Rasburicase · interactions on record
25 records
- 1 severe
- 24 moderate
Most severe, free to view
- PrilocaineN01BB04severe
- LidocainA01AE01moderate
- TetracainA01AE02moderate
- LidocaineC05AD01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Rasburicase in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandFasturtecSanofi Winthrop Industrie
- SwitzerlandFasturtec 1.5 mg / 1 ml, poudre et solvant pour solution à diluer pour perfusionSanofi-Aventis (Suisse) SA
- Japanラスブリカーゼ（遺伝子組換え）サノフィ
- CzechiaFASTURTECSanofi Winthrop Industrie, Gentilly
- SpainFASTURTEC 1,5 MG/ML POLVO Y DISOLVENTE PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONSanofi Winthrop Industrie
- BelgiumFasturtec 1.5 mg/mlSanofi Winthrop Industrie
- NetherlandsFasturtec 1,5 mg/ml poeder en oplosmiddel voor concentraat voor oplossing voor infusieSanofi Winthrop Industrie
- NorwayFasturtecSanofi Winthrop Industrie
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Fasturtec
- Liechtenstein · Fasturtec
- Norway · Fasturtec
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a26ee6ce-9d7a-4efa-9435-59a58ed8e763 GET /v1/drugs/a26ee6ce-9d7a-4efa-9435-59a58ed8e763?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "4845411000001100",
"desc": "Fasturtec 1.5mg powder and solvent for solution for infusion vials (Sanofi)",
"form": "Powder and solvent for solution for infusion",
"vpid": "35934111000001106",
"source": "dmd",
"vtm_id": "777402002",
"strength": "1.5 mg",
"substance": "Rasburicase",
"ingredient": "Rasburicase",
"supplier_code": "9190711000001101"
}See everything about rasburicase.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.